Close
Nordic 9Nordic 9

Oji Holdings Corporation (investor - Corporate Investor)

Japan
See something wrong or missing? Let us know
Offices:Tokyo
Average round investment:N/A USD
Average number per year:0.0
Distribution: 2026 (1)
Portfolio companies: Finland Nordic Bioproducts Group
Mostly invests in: Finland Finland (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Oji Holdings Corporation

Name Criteria
Switzerland SNGLR Capital
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Active last 12 months: Yes
Austria Biogena Group Invest Ag
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Active last 12 months: Yes
Germany Ortho Innovations
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Sweden Triathlon Group
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Sweden Ekeblad Bostad
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Belgium Annemie Van de Casteele
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Active last 12 months: Yes
Belgium Griet Nuytinck
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Active last 12 months: Yes
Belgium Virginie Saverys
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Active last 12 months: Yes
Italy Golgi NueroSciences
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Sweden Anders Bergkvist
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Top